← All trials
NCT02149537
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2014
- Primary completion
- Aug 1, 2017
- Completion date
- Aug 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Loyola UniversityLead sponsor
- Loyola UniversityOverall official - principal investigator
- University of IbadanOverall official - principal investigator
- Loyola UniversityReponsible party - principal investigator
- University of IbadanCollaborator
- University of Illinois at ChicagoOverall official - principal investigator
- University of Illinois at ChicagoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.